The Online Investor
Drugs & Pharmaceuticals M&A image Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Mon., May. 23, 9:22 AM Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.

Slide #69. McKesson Celesio

Acquirer: McKesson (NYSE:MCK)
Acquiree: Celesio
Details: McKesson Corporation [NYSE: MCK] ("McKesson"), a leading North American healthcare services and information technology company, and Celesio AG [ISIN DE000CLS1001] ("Celesio"), a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors, announced today that McKesson has signed an agreement to acquire a majority stake in Celesio for 23 per share and to launch parallel voluntary public tender offers for the remaining publicly-traded shares and outstanding convertible bonds of Celesio. The offer price of 23 per share represents a 39% premium over the three-month volume weighted average price prior to the market speculation that began on October 8, 2013. The total transaction, including the assumption of Celesio's outstanding debt, is valued at approximately $8.3 billion(6.1 billion)*.

McKesson is engaged in healthcare services. Co. operates its business in four reportable segments: U.S. Pharmaceutical, which distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; Prescription Technology Solutions, which delivers access and adherence solutions as well as dispensing support services, third-party logistics and wholesale distribution support; Medical-Surgical Solutions, which provides medical-surgical supply distribution, logistics, and other services to healthcare providers; and International, which provides distribution and services to wholesale, institutional, and retail customers.

McKesson SEC Filing Email Alerts Service


Open the MCK Page at The Online Investor »

Company Name: 
McKesson Corp
Website: 
www.mckesson.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding MCK: 
108
Total Market Value Held by ETFs: 
$6.55B
Total Market Capitalization: 
$48.03B
% of Market Cap. Held by ETFs: 
13.64%
 

Open the MCK Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree MCK Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (3.59 out of 4)
50th percentile
(ranked higher than approx. 50% of all stocks covered)

Analysts' Target Price:
MCK Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Drugs & Pharmaceuticals M&A - Slide 69 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.